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SUMMARY
Background. Data on human immunodefi-
ciency virus (HIV) infected patients receiving
dialysis in Portugal is scarce.
Methods. This nationwide epidemiological
survey retrospectively evaluates HIV-infected
patients on chronic dialysis in Portugal between
1997 and 2002.
Results. Sixty-six patients were evaluated
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(mean age: 39.1±1.6 years, 47 men, 35 black
African). Sixty-two patients started dialysis and
4 patients who were receiving dialysis had HIV
seroconversion. Eighty-five percent of patients
were treated in Lisbon. The annual incidence of
HIV-infected patients on chronic dialysis was
0.5% in 1997 and 0.9% in 2002. Seventy-eight
percent of patients were HIV-1 infected , 13%
had hepatitis B and 31% hepatitis C. Sexual
contact was the mode of transmission of HIV in
53% of cases. Four patients had biopsy-proved
HIV-associated nephropathy. Ninety-five percent
of patients were on chronic hemodialysis. Fifty
percent of patients had acquired immunodefi-
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ciency syndrome. At follow-up, 12 patients died.
HIV-infected CKD patient survival after starting
dialysis was 80% at 3 years.
Conclusion. The incidence of HIV-infected
patients on chronic dialysis in Portugal has al-
most doubled. Widespread use of highly active
antiretroviral therapy and the increasing number
of black Africans from former overseas Portu-
guese colonies now living in Portugal are possi-
ble reasons for this large increase.
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INTRODUCTION
The growing epidemic of the human immu-
nodeficiency virus (HIV) infection has resulted
in a large increase in the number of patients
developing chronic kidney disease (CKD), re-
quiring maintenance dialysis. HIV infection in
patients on maintenance dialysis could result
from infection prior to the beginning of dialysis
or from the seroconversion after the initiation of
dialysis. Chronic kidney disease in HIV-infected
patients is a result of HIV-associated nephropa-
thy (HIVAN) or an unrelated intrinsic primary or
secondary renal disease1.
HIVAN is a well known condition character-
ized by progressive glomerulosclerosis with
“malignant” nephrotic syndrome and progression
to uraemia. It is the first cause of CKD in HIV-
infected patients2 and is more frequent in non-
Caucasian patients3. In addition, non-HIV CKD
patients on renal replacement therapy may ac-
quire HIV infection from sexual contact, needle
sharing and blood transfusions1. HIV transmis-
sion in dialysis centres and from transplanted
organs is almost inexistent1.
There are few epidemiological studies focus-
ing on HIV infection in dialysis patients4-7. In or-
der to evaluate the demographic and clinical
characteristics of HIV-infected patients receiv-
ing dialysis in Portugal we undertook a nation-
wide epidemiological study involving the dialy-
sis units providing care for these patients.
SUBJECTS AND METHODS
This retrospective study describes the demo-
graphic and clinical characteristics of HIV-in-
fected patients with CKD receiving dialysis in
Portugal between January 1997 and December
2002.
A questionnaire was mailed in January 2003
to the medical directors of the Portuguese di-
alysis units treating HIV-infected patients. Pa-
tients were divided into two groups:  Group 1-
HIV-infected CKD patients at initiation of chronic
dialysis; group 2- CKD patients on chronic di-
alysis who had HIV seroconversion. Epidemio-
logical data (age, gender, race, nationality), clini-
cal and laboratorial HIV-related variables (date
of diagnosis, mode of transmission, type of HIV,
hepatitis B and hepatitis C coinfection, and the
stage of HIV disease according to the Centers
for Disease Control and Prevention (CDC) clas-
sification, CD4+ lymphocyte count, HIV viral load
and antiretroviral therapy at the time of data col-
lection or the last follow-up) and CKD and dialy-
sis related information (date of diagnosis and
aetiology of renal disease, dialysis modality, date
of initial dialysis, date and cause of death) were
collected from dialysis units databases.
Statistical analysis
All continuous variables are presented as
mean ± standard deviation. Categorical variables
are presented as percentage of number of
cases.
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RESULTS
From January 1997 - December 2002, 66
HIV-infected patients (groups 1 and 2) were
treated in 14 dialysis units (Figure 1). Lisbon had
the highest number of units (6 units) and pa-
tients (56 patients). The annual incidence of HIV-
infected patients on chronic dialysis was 0.5%
in 1997, 0.4% in 1998, 0.3% in 1999, 0.7% in
2000, 0.6% in 2001 and 0.9% in 2002 (Table 1).
Table 2 summarizes the clinical characteris-
tics of patients studied. At the initiation of dialy-
sis or at the seroconversion, the mean age of
the patients was 39.1±1.6 years, and 71% were
men. Thirty-five (53%) patients were black Afri-
can immigrants from Portuguese Speaking Afri-
can Countries, all of them being treated in Lis-
Figure 1 – Geographic distribution of dialysis units and HIV-infected patients on maintenance dialysis in
Portugal. U- Units; pt(s)- patient(s)
Table I
Total number of patients and HIV-infected patients
starting dialysis / year
Year Patients HIV-infected patients
starting dialysis starting dialysis
1997 1640 8 (0.5%)
1998 1760 7 (0.4%)
1999 1944 6 (0.3%)
2000 1895 14 (0.7%)
2001 2051 13 (0.6%)
2002 2084 18 (0.9%)
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Table II
Clinical characteristics of HIV-infected patients on maintenance dialysis in Portugal.
*Among patients with available results (an=62, bn=64, cn=58, dn=51, en=36, fn=46)
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bon. In 22% of cases, the time elapsing since
their arrival in Portugal and the beginning of di-
alysis was less than one month.
Between January 1997 and December 2002,
62 HIV-infected CKD patients started dialysis
(group 1). The average length of time from HIV
infection diagnosis to the beginning of renal re-
placement therapy was 5.2±1.7 years, but in
35% of patients HIV infection was documented
in routine serologic evaluation always performed
at first dialysis. The aetiology of CKD was dia-
betes mellitus in 10 cases, chronic glomerulone-
phritis in 9, hypertension in 5, biopsy-proved
HIVAN in 4, autosomal dominant polycystic kid-
ney disease in 2, acute tubular necrosis with no
renal function recovery in 1 and it was unknown
in 31. In group 1, patient survival after starting
dialysis was 87.6% at 1 year, 81.7% at 2 years
and 80% at 3 years.
Four patients on maintenance hemodialysis
had HIV seroconversion (group 2). The aetiol-
ogy of CKD was diabetes mellitus in 3 patients
and autosomal dominant polycystic kidney dis-
ease in 1 patient. The mean time from the initia-
tion of dialysis and HIV infection diagnosis was
29.8 months. In this group, the mode of trans-
mission was heterosexual contact in 2 patients,
blood transfusion in 1 and unknown in the re-
maining patient. At the time of seroconversion
none of these patients were treated in dialysis
units taking care of HIV-infected patients.
Overall, 52 patients were infected with HIV-
1, 11 patients with HIV-2 and 3 patients with HIV-
1 and HIV-2. Fifty percent of patients had ac-
quired immunodeficiency syndrome (AIDS),
31% had a CD4+ lymphocyte count below 200
cells/mL and 90% had a viral load lower than
55000 copies/mL. Sixty-five percent of patients
were treated with highly-active antiretroviral
therapy (HAART). Three patients who had a
CD4+ lymphocyte count below 200 cells/mL and
4 patients with AIDS were not on antiretroviral
therapy (1 being resistant to all drugs, 2 refus-
ing all medication and the remaining for unknown
reasons). Thirteen percent of patients tested
HBsAg positive, 31% had reactive antibody tests
for hepatitis C and 2 patients had both hepatitis
B and C coinfection. Ninety-five percent of pa-
tients were on chronic hemodialysis and the re-
maining were on a peritoneal dialysis pro-
gramme (2 in automated peritoneal dialysis and
1 in ambulatory continuous peritoneal dialysis).
At follow-up, 12 patients (11 from group 1) died.
The cause of death was due to sepsis in 5 cases,
cardiovascular disease in 4, cancer in 1, mal-
nutrition in 1 and unknown cause in 1. Two pa-
tients died in 2001 and 10 in 2002.
DISCUSSION
This was the first epidemiological study per-
formed in Portugal to evaluate the demographic
and clinical characteristics of HIV-infected pa-
tients receiving dialysis.
The incidence of HIV-infected patients on
chronic dialysis in Portugal almost doubled be-
tween 1997 and 2002. This data suggests that,
in line with that described in other countries,7
this population of patients is growing in number.
Possible reasons for the large increase reported
in our survey are the use of HAART, a better
management of opportunistic infections and the
increasing number of black Africans from former
overseas Portuguese colonies living in Portu-
gal. The widespread use of HAART since 1997
and a better prophylaxis and treatment of op-
portunistic infections have largely contributed to
a better survival of HIV-infected patients, allow-
ing them to live long enough to reach CKD.  In
fact, HAART has clearly changed the profile of
HIV patients, improving their outcome signifi-
cantly8. We must remember that in the current
analysis all patients started dialysis during the
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HAART era. In addition, there were a great pro-
portion of black African patients from Portuguese
Speaking African Countries, where HIV infec-
tion is endemic, who significantly contributed to
the overall incidence of HIV-infected patients
receiving dialysis. Similarly, in the United States
(6,9,10) and France5,7 there is also a great pro-
portion of non-Caucasian patients among HIV-
infected CKD patients on chronic dialysis.
Lisbon had the highest number of patients
and units caring for HIV-infected patients. The
prevalence of HIV infection in various dialysis
units depends on the demographics of the popu-
lation and tends to be greater in urban centres
with a large African population2. In the present
study, more than one half of patients were black
African and all of them were undergoing dialy-
sis in Lisbon. This data might be related to the
significantly great proportion of population from
former Portuguese overseas colonies now liv-
ing in this city.
Only 4 patients had biopsy-proved HIVAN
which is in sharp contrast with other studies6, 11-13.
In the present study, 22% of black African pa-
tients started dialysis in the first month following
their arrival to Portugal, 35% of patients had HIV
infection documented at first dialysis and in one
half of cases the aetiology of renal disease was
unknown. These data can lead us to speculate
that the lower incidence of HIVAN might be re-
lated to the great number of patients who pre-
sented with advanced CKD. Given that non-in-
vasive tests are unable to distinguish between
HIVAN and other lesions, the lower prevalence
of HIVAN documented in the current study sug-
gests an underestimation of its frequency.
Similarly to that reported in other studies,6 the
number of patients on maintenance dialysis who
had HIV seroconversion was low and not related
to dialysis procedures.
In our study, HIV-infected CKD patient sur-
vival after starting dialysis was 87.6% at 1 year,
81.7% at 2 years and 80% at 3 years which is
concordant to other recent studies2,10 that re-
ported an improvement in survival of HIV-in-
fected patients receiving dialysis. Although a
number of factors have been suggested as con-
tributing to the better prognosis of HIV-infected
patients with CKD, such as a better nutritional
support, more efficient dialysis delivery and cor-
rection of anaemia1, the availability and use of
HAART is most likely responsible for the im-
provement in survival2.
In sum, we show that annual incidence of HIV-
infected patients receiving dialysis in Portugal
almost doubled between 1997 and 2002, sug-
gesting that there is a trend towards an increas-
ing incidence of this set of patients in the Portu-
guese dialysis units.
Corresponding author:
Dr José António Lopes
Hospital de Santa Maria
Nephrology Department
Av. Prof. Egas Moniz, 1639-045 Lisboa, Portugal
e-mail: jalopes93@hotmail.com
REFERENCES
  1. Rao TK. Human immunodeficiency virus infection in end-
stage renal disease patients. Semin Dial 16:233-244, 2003
  2. Ahuja TS, O’Brien WA. Special issues in the manage-
ment of patients with ESRD and HIV Infection. Am J Kid-
ney Dis  41: 279-291, 2003
  3. Martinez F.Néphropathie liée au VIH: aspects
épidémiologiques et thérapeutiques. Néphrologie 22: 299-
300, 2001
   4. Di Belgiojoso GB, Trezzi M, Scorza D, et al. HIV infection
in dialysis centers in Italy: a Nationwide Multicenter Study.
J Nephrol 11: 249-254, 1998
  5. Poignet JL, Desassis JF, Chanton N, et al. Prévalence
de l’infection à VIH chez les patients dialysés: résultats
d’une enquête multicentrique nationale. Néphrologie 20:
159-163,1999
Revista Portuguesa de Nefrologia e Hipertensão 207
DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED
PATIENTS RECEIVING DIALYSIS IN PORTUGAL: A NATIONWIDE MULTICENTRE SURVEY
  6. Szczech LA, Kalayjian R, Rodriguez R, Gupta S,
Coladonato J, Winston J. The clinical characterisitcs
and antiretroviral dosing patterns of HIV-infected pa-
tients receiving dialysis. Kidney Int 63: 2295-2301,
2003
  7. Vigneau C, Guiard-Schmid JB, Tourret J et al. The clini-
cal characteristics of HIV-infected patients receiving di-
alysis in France between 1997 and 2002. Kidney Int 67:
1509-1514, 2005
  8. Ahuja TS, Grady J, Khan S. Changing trends in the sur-
vival of dialysis patients with human immunodeficiency
virus in the United States. J Am Soc Nephrol 13: 1889-
1993, 2002
  9. Ahuja TS, Collinge N, Grady J, Khan S. Is dialysis modal-
ity a factor in survival of patients with ESRD and HIV-
associated nephropathy? Am J Kidney Dis 41: 1060-1064,
2003
10. Rodriguez RA, Mendelson M, O ?Hare AM, Hsu LC,
Schoenfeld P. Determinants of survival among HIV-in-
fected chronic dialysis patients. J Am Soc Nephrol 14:
1307-1313, 2003
11. Winston JA, Klotman ME, Klotman PE: HIV-associated
nephropathy is a late, not early, manifestation of HIV-1
infection. Kidney Int 55:1036-1040, 1999
12. Ahuja TS, Borucki M, Funtanilla M, et al: Is the preva-
lence of HIV-associated nephropathy decreasing? Am J
Nephrol 19:655-659, 1999
13. Shahinian V, Rajaraman S, Borucki M, et al: Prevalence
of HIV-associated nephropathy in autopsies of HIV-in-
fected patients. Am J Kidney Dis 35:884-888, 2000
